Chart-Typ:
Zeitraum:
| 3D Systems Announces Major Milestone in Digital Dentistry with Full Commercial Release of New FDA-cleared Denture Solution | Company's technology redefines dental prosthetics with revolutionary single-piece, multi-material dentures delivering distinctive combination of exquisite aesthetics, comfort and outstanding resistance... ► Artikel lesen |
| 3D Systems Advances Regenerative Medical Solutions for First-of-its-Kind Peripheral Nerve Repair | Collaboration with French MedTech company, TISSIUM, has resulted in FDA approval for unique 3D-printed polymeric solution for repair of peripheral nerve damage3D Systems' bioprinting system enabled... ► Artikel lesen |
| 3D Systems Announces Significant Strengthening of Balance Sheet | Transactions permanently retire approximately $88 million of debt, 41% of prior balance, at a meaningful discount to parRefinancing extends maturity with issuance of $92 million Convertible Senior... ► Artikel lesen |
| UltiMaker Unveils the UltiMaker S8, Engineered for Enhanced Productivity and Precision | The UltiMaker S8 delivers up to 4x more productivity and improved part quality, without sacrificing security, reliability or ease of use.
Combined with new materials in the UltiMaker... ► Artikel lesen |
| VivoSim Labs, Inc.: VivoSim Announces Emergence from Stealth Mode To Provide Technologies for FDA Turn Away from Animal Models, $10B+ Market | SAN DIEGO, April 24, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the "Company") announced that it has emerged from stealth mode to dramatically impact drug discovery and development.... ► Artikel lesen |
| Organovo, Inc.: Organovo Provides Update on Cash and Nasdaq Continued Listing Requirements | SAN DIEGO, April 02, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
| Organovo, Inc.: Organovo Provides Business Update | SAN DIEGO, March 27, 2025 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO) ("Organovo" or the "Company"), a clinical stage biotechnology company focused on developing novel treatment approaches... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu WELLFULLY LIMITED finden Sie auf Wallstreet Online.